)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Lipidor
Lipidor (LIPI) investor relations material
Lipidor has been delisted
Lipidor Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2024 earnings summary28 Feb, 2025
Executive summary
Achieved key milestones including successful refinancing and initiation of Phase III clinical trial for psoriasis candidate AKP02G2; first patient recruited in September 2024 and half of patients randomized by January 2025.
Results from the Phase III study are expected in April 2025, with preparations underway for regulatory submission and potential product registration.
Financial highlights
Net sales for Jan–Dec 2024 were 14 tkr (78 tkr year-over-year); H2 2024 net sales were 0 tkr (70 tkr year-over-year).
Operating loss for Jan–Dec 2024 was -14,210 tkr (-15,454 tkr year-over-year); H2 2024 operating loss was -8,576 tkr (-9,573 tkr year-over-year).
Net result for Jan–Dec 2024 was -13,806 tkr (-11,485 tkr year-over-year); H2 2024 net result was -8,517 tkr (-8,239 tkr year-over-year).
Cash flow for Jan–Dec 2024 was 9,587 tkr (-8,299 tkr year-over-year), mainly due to new share issues and asset sales; cash and cash equivalents at year-end were 10,215 tkr (628 tkr prior year).
Equity per share at year-end was 0.01 SEK (-0.32 SEK prior year); equity ratio improved to 66.68% from -330.70%.
Outlook and guidance
Phase III study results for AKP02G2 expected in April 2025; positive results could enable product registration and market launch with partner Menarini/Relife.
Current liquidity is sufficient to complete the ongoing clinical trial, but further funding will be needed for operations beyond the next 12 months.
Additional liquidity may be secured via milestone payments and exercise of TO 2 warrants, contingent on study outcome and share price.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lipidor
Lipidor
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Lipidor AB is a Swedish company based in Stockholm that specializes in developing topical treatments utilizing unique lipid-based formulations. Their primary focus is on creating formulations for psoriasis treatments. The company leverages its proprietary AKVANO technology, which enables the formation of a lipid layer on the skin surface, facilitating effective drug delivery and skin care treatments. Lipidor collaborates with various global pharmaceutical companies, providing formulation concepts and technologies aimed at improving patient quality of life. They manage the entire development process from preclinical stages to clinical trials, often partnering with external companies for manufacturing and clinical studies. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.